Companies / Acadia Pharmaceuticals Inc.

Case file: Acadia Pharmaceuticals Inc.

Every government filing on this incident, the dates as stated, and the days to notice against each state's statute. Built from the records on Nov 9, 2026, agency link on every row. Not legal advice.

Download as a Word documentAll filings by Acadia Pharmaceuticals Inc.

The incident

Breach window
Nov 4, 2024
Discovered
Nov 4, 2024, as stated in the California letter
State and federal records
2 filings, Dec 4, 2024
Residents counted
No state publishes a resident count for this incident
Everyone affected
14,065, as reported to Oregon DOJ on Dec 4, 2024
Information exposed
Medical / health information, Email address
Offered to those affected
No monitoring offer found in the letters we read
Third party named
No
Days to notice
Within the statutory period in all 2 states that set one, counted from discovery to each state's first record
Prior incidents
1 earlier incident on record for this organization

The letter: "Acadia became aware of this incident on November 4, 2024 and promptly began to investigate and assess the impact of the incident."

Filings

AgencyRecord datePeopleIn totalDays to noticeLinks
Oregon
Oregon DOJ
Dec 4, 202414,065 (total)30 days, statute 45 days Record
California
California AG
Dec 4, 2024Not published30 days, statute 30 daysLetter Record

People is the count the filing gives, residents of the state unless marked total. Days to notice runs from the discovery date the letter states, or from the end of the breach window when no letter states one, to the date on the state's first record of the incident. "Over" marks a count past the days the state's statute allows for notice to residents. The statute's trigger is a question of fact, the days are arithmetic.

Notice timing, state by state

The statutes

Prior incidents by Acadia Pharmaceuticals Inc.

RecordsBreach windowFiled withPeople
May 21, 2024Feb 21, 2024Californian/a

Filings more than six months apart are shown as separate incidents.

Sources and method

Records as published by Oregon DOJ, California AG. Letter facts (discovery date, monitoring, third party) are read from the consumer letter the agency posted, 1 letter read for this incident, and quoted so you can check them. Texas and HHS publish no letters. First-seen times on each record page. Spot an error? Email support@breachtally.com with this page link.

The next state to file on Acadia Pharmaceuticals Inc. reaches subscribers within the hour, and the case file updates itself. Start a 14-day free trial.